Recent studies indicate that the coronavirus is triggering many new autoimmune and neurological diseases. That's good news for chronic fatigue syndrome (ME/CFS)
Anticoagulant and anti-platelet therapy reduces symptoms significantly in long COVID. The implications for chronic fatigue syndrome (ME/CFS), fibromyalgia and POTS are discussed.
An innovative gene expression study suggests that an immune cell that's hardly been studied in chronic fatigue syndrome - monocytes - could be the prime driver of the immune problems in the disease.
Keep the information flowing! Support Health Rising during our end of the year fundraising drive. Click here for more.
Stay Up to Date with ME/CFS, Long COVID and Fibromyalgia News
Get Health Rising's free blogs featuring the latest findings and treatment options for the ME/CFS, long COVID, fibromyalgia and complex chronic disease communities.